PDA responds to GPhC consultation on managing concerns about pharmacy professionals

The GPhC recently consulted on its Fitness to Practise (FtP) strategy titled ‘Managing concerns about pharmacy professionals: Our strategy for change’.

Mon 17th May 2021 The PDA

The PDA welcomed the ethos of reform as it is long overdue. However, the PDA expressed concern about the timing of these proposals as the Government has already indicated that major changes to how regulators function, especially their fitness to practice processes are imminent. The PDA also noted that the GPhC had not met the standards required by The Professional Standards Authority (PSA) in regard to its existing fitness to practice processes.

Thus, the PDA made a number of recommendations around interim measures that the GPhC could undertake to meet PSA standards whilst awaiting the major changes planned by the Government. These interim measures included:

(1) The GPhC should consider putting into place enhanced support measures for both registrants and complainants.

(2) It should focus on improving the timeliness to case closure.

(3) It should start the process of recruiting BAME panellists so that when cases go to hearings (for the most serious cases) the diversity of the profession is reflected in the panel.

(4) It should ensure that all cases are fully documented and follow internal guidance.

(5) It should ensure that diversity data is captured and recorded at the point of raising concern and all subsequent stages.

(6) The GPhC should start to identify how it will meaningfully apply the same standards to premises owners as it does to individual registrants.

(7) It should have a full and meaningful Equality, Diversity, and Inclusion (EDI) policy in place so that any reformed FtP fits into the overarching legal requirement of its statutory EDI obligations.

Download the PDA’s full response here

thumbnail of GPhC FTP consultation FINAL

DOWNLOAD THE CONSULTATION DOCUMENT HERE

thumbnail of 001 gphc-managing-concerns-about-pharmacy-professionals-our-strategy-for-change-consultation-october-2020_0

The consultation ran from 27/10/2020 to 22/01/2021.

 

 

 

 

 

 

 

The Pharmacists' Defence Association is a company limited by guarantee. Registered in England; Company No 4746656.

The Pharmacists' Defence Association is an appointed representative in respect of insurance mediation activities only of
The Pharmacy Insurance Agency Limited which is registered in England and Wales under company number 2591975
and is authorised and regulated by the Financial Conduct Authority (Register No 307063)

The PDA Union is recognised by the Certification Officer as an independent trade union.

Cookie Use

This website uses cookies to help us provide the best user experience. If you continue browsing you are giving your consent to our use of cookies.

General Guidance Resources Surveys PDA Campaigns Regulations Locums Indemnity Arrangements Pre-Regs & Students FAQs Coronavirus (COVID-19)